1、 PATELIYA B,BURADE V,GOSWAMI S.Combining naringenin and metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo[J].Eur J Pharmacol,2021(891):173725. PATELIYA B,BURADE V,GOSWAMI S.Combining naringenin and metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo[J].Eur J Pharmacol,2021(891):173725.
2、 PATELIYA B,BURADE V,GOSWAMI S.Enhanced antitumor activity of doxorubicin by naringenin and metformin in breast carcinoma:An experimental study[J].Naunyn Schmiedebergs Arch Pharmacol,2021,394(9):1949-1961. PATELIYA B,BURADE V,GOSWAMI S.Enhanced antitumor activity of doxorubicin by naringenin and metformin in breast carcinoma:An experimental study[J].Naunyn Schmiedebergs Arch Pharmacol,2021,394(9):1949-1961.
3、 XU Z,HUANG B,LIU J,et al.Combinatorial anti-proliferative effects of tamoxifen and naringenin:The role of four estrogen receptor subtypes[J].Toxicology,2018(410):231-246. XU Z,HUANG B,LIU J,et al.Combinatorial anti-proliferative effects of tamoxifen and naringenin:The role of four estrogen receptor subtypes[J].Toxicology,2018(410):231-246.
4、 ZHANG F,DONG W,ZENG W,et al.Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation[J].Breast Cancer Res,2016,18(1):38. ZHANG F,DONG W,ZENG W,et al.Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation[J].Breast Cancer Res,2016,18(1):38.
5、 QI Z,KONG S,ZHAO S,et al.Naringenin inhibits human breast cancer cells(MDA-MB-231)by inducing programmed cell death,caspase stimulation,G2/M phase cell cycle arrest and suppresses cancer metastasis[J].Cell Mol Biol(Noisy-le-grand),2021,67(2):8-13. QI Z,KONG S,ZHAO S,et al.Naringenin inhibits human breast cancer cells(MDA-MB-231)by inducing programmed cell death,caspase stimulation,G2/M phase cell cycle arrest and suppresses cancer metastasis[J].Cell Mol Biol(Noisy-le-grand),2021,67(2):8-13.
6、 LI Q,WANG Y,ZHANG L,et al.Naringenin exerts anti-angiogenic effects in human endothelial cells:Involvement of ERRα/VEGF/KDR signaling pathway[J].Fitoterapia,2016(111):78-86. LI Q,WANG Y,ZHANG L,et al.Naringenin exerts anti-angiogenic effects in human endothelial cells:Involvement of ERRα/VEGF/KDR signaling pathway[J].Fitoterapia,2016(111):78-86.
7、 ZHAO Z,JIN G,GE Y,et al.Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways.Inflamopharmacology[J].2019,27(5):1021-1036. ZHAO Z,JIN G,GE Y,et al.Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways.Inflamopharmacology[J].2019,27(5):1021-1036.
8、 WANG R,WANG J,DONG T,et al.Naringenin has a chemoprotective effect in MDA-MB-231 breast cancer cells via inhibition of caspase-3 and -9 activities[J].Oncol Lett,2019,17(1):1217-1222. WANG R,WANG J,DONG T,et al.Naringenin has a chemoprotective effect in MDA-MB-231 breast cancer cells via inhibition of caspase-3 and -9 activities[J].Oncol Lett,2019,17(1):1217-1222.
9、 AHAMAD M S,SIDDIQUI S,JAFRI A,et al.Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest[J].PLoS One,2014,9(10):e110003. AHAMAD M S,SIDDIQUI S,JAFRI A,et al.Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest[J].PLoS One,2014,9(10):e110003.
10、 OZYüREK M,AKP?NAR D,BENER M,et al.Novel oxime based flavanone,naringin-oxime:Synthesis,characterization and screening for antioxidant activity[J].Chem Biol Interact,2014(212):40-46. OZYüREK M,AKP?NAR D,BENER M,et al.Novel oxime based flavanone,naringin-oxime:Synthesis,characterization and screening for antioxidant activity[J].Chem Biol Interact,2014(212):40-46.
11、 ZHANG J,WANG N,ZHENG Y,et al.Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway[J].J Adv Res,2023(47):189-207. ZHANG J,WANG N,ZHENG Y,et al.Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway[J].J Adv Res,2023(47):189-207.
12、 KIM S,PARK T I.Naringenin:A partial agonist on estrogen receptor in T47D-KBluc breast cancer cells[J].Int J Clin Exp Med,2013,6(10):890-899. KIM S,PARK T I.Naringenin:A partial agonist on estrogen receptor in T47D-KBluc breast cancer cells[J].Int J Clin Exp Med,2013,6(10):890-899.
13、 KUIPER G G,LEMMEN J G,CARLSSON B,et al.Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta[J].Endocrinology,1998,139(10):4252-4263. KUIPER G G,LEMMEN J G,CARLSSON B,et al.Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta[J].Endocrinology,1998,139(10):4252-4263.
14、 ZOU W,LUO Y,LIU M,et al.Human intestinal microbial metabolism of naringin[J].Eur J Drug Metab Pharmacokinet,2015,40(3):363-367. ZOU W,LUO Y,LIU M,et al.Human intestinal microbial metabolism of naringin[J].Eur J Drug Metab Pharmacokinet,2015,40(3):363-367.
15、 BHIA M,MOTALLEBI M,ABADI B,et al.Naringenin nano-delivery systems and their therapeutic applications[J].Pharmaceutics,2021,13(2):291. BHIA M,MOTALLEBI M,ABADI B,et al.Naringenin nano-delivery systems and their therapeutic applications[J].Pharmaceutics,2021,13(2):291.
